Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
NN
Anbio Biotechnology Class A Ordinary Shares
NNNN
Mkt Cap
$142.0M
Volume
38.34K
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
NN
NNNN
NN
Anbio Biotechnology Class A Ordinary Shares
NNNN
News
·
Trump Sparks A 2025 IPO Boom: 5 New Stocks Have Rallied Over 400%
Mkt Cap
$137.4M
Volume
38.34K
Next Earnings
N/A
Chart
Financials
Earnings
News
About
Insider
Filings
Trump Sparks A 2025 IPO Boom: 5 New Stocks Have Rallied Over 400%
The U.S. IPO market is experiencing a strong revival in 2025, with 163 companies going public and raising $31 billion, driven by a favorable business climate under President Trump's second term and increased investor risk appetite.
Benzinga · Oct 7, 2025
Anbio Biotechnology Responds to Global Outbreaks with Chikungunya Rapid Test and New 15-Minute Ultra-Fast PCR System
Anbio Biotechnology launched a Chikungunya IgM/IgG Rapid Test and an AP-100 Ultra-Fast PCR system to support rapid diagnostic testing for infectious diseases, enabling quick detection of pathogens in both centralized and decentralized healthcare settings.
GlobeNewswire Inc. · Aug 9, 2025
Amaran Biotech Signs MOU with Nippon Fine Chemical
Amaran Biotechnology, a subsidiary of OBI Pharma, and Nippon Fine Chemical, a Japanese company, have signed an MOU to collaborate in nanoparticle-based drug CDMO manufacturing. The partnership aims to leverage their respective strengths to expand their presence in Taiwan, Japan, and international CDMO markets.
GlobeNewswire Inc. · Mar 7, 2025
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
NN
NNNN
Anbio Biotechnology Class A Ordinary Shares
Buy
Sell
Market
Limit
Soon
NNNN
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any NNNN yet.
Related Tickers
Earnings